Related references
Note: Only part of the references are listed.Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M
Makoto Kurano et al.
ATHEROSCLEROSIS (2013)
Plasma Sphingosine-1-Phosphate Is Elevated in Obesity
Greg M. Kowalski et al.
PLOS ONE (2013)
Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges
Uchechukwu K. Sampson et al.
CURRENT ATHEROSCLEROSIS REPORTS (2012)
Targeting HDL-cholesterol to reduce residual cardiovascular risk
Alma O. Iacob et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Modulation of lipid metabolism with the overexpression of NPC1L1 in mouse liver
Makoto Kurano et al.
JOURNAL OF LIPID RESEARCH (2012)
The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles
Christina Christoffersen et al.
JOURNAL OF LIPID RESEARCH (2012)
Apolipoprotein E Mediates Enhanced Plasma High-Density Lipoprotein Cholesterol Clearance by Low-Dose Streptococcal Serum Opacity Factor via Hepatic Low-Density Lipoprotein Receptors In Vivo
Corina Rosales et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
The Evolving Role of HDL in the Treatment of High-Risk Patients with Cardiovascular Disease
H. Bryan Brewer
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease
Kelley M. Argraves et al.
LIPIDS IN HEALTH AND DISEASE (2011)
LXR agonist increases apoE secretion from HepG2 spheroid, together with an increased production of VLDL and apoE-rich large HDL
Makoto Kurano et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
Christina Christoffersen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus
Paul J. W. H. Kappelle et al.
ATHEROSCLEROSIS (2010)
Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease
Katherine J. E. Sattler et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Opposing Effects of Apolipoprotein M on Catabolism of Apolipoprotein B-Containing Lipoproteins and Atherosclerosis
Christina Christoffersen et al.
CIRCULATION RESEARCH (2010)
Plasma sphingosine 1-phosphate metabolism and analysis
Yutaka Yatomi
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters
Ryunosuke Ohkawa et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2008)
HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects
Kelley M. Argraves et al.
JOURNAL OF LIPID RESEARCH (2007)
An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma
Olof Axler et al.
JOURNAL OF LIPID RESEARCH (2007)
Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells
Takao Kimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Isolation and characterization of human apolipoprotein M-containing lipoproteins
Christina Christoffersen et al.
JOURNAL OF LIPID RESEARCH (2006)
Sphingosine 1-phosphate in vascular biology: Possible therapeutic strategies to control vascular diseases
Y Yatomi
CURRENT PHARMACEUTICAL DESIGN (2006)
A two-module region of the low-density lipoprotein receptor sufficient for formation of complexes with apolipoprotein E ligands
C Fisher et al.
BIOCHEMISTRY (2004)
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
JR Nofer et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Structural and functional characteristics of S1P receptors
T Sanchez et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability
T Sanchez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Isoform-dependent cholesterol efflux from macrophages by apolipoprotein E is modulated by cell surface proteoglycans
M Hara et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?
F Okajima
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Sphingosine 1-phospbate and activation of endothelial nitric-oxide synthase - Differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells
J Igarashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Pleiotypic mechanisms of cellular responses to biologically active lysophospholipids
EJ Goetzl
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2001)
Share Paper
